All In MedTech

Device Trial Radar · NCT04010617

PES to Avoid Extubation Failure in Intubated Stroke Patients at High Risk of Severe Dysphagia

Pharyngeal Electrical Stimulation (PES) to Avoid Extubation Failure in Intubated Stroke at High Risk of Severe Dysphagia

Last checked: Nov 19, 2026Latest source record: Jul 8, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

30

Planned (sponsor's estimate)

Start

Jul 1, 2018

Primary completion

Nov 1, 2019

Study completion Dec 31, 2019

Sponsor

Lead sponsor
University Hospital MuensterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 8, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Post-extubation dysphagia (PED) recently became a growing concern as a major risk factor for extubation failure and significant contributor to poor patient outcomes with prevalence rates ranging from 12% to 69%, being highest in neurological patients (93%). Pharyngeal electrical stimulation (PES) has been shown to improve airway safety and swallowing function tracheostomized stroke patients, thereby enhancing decannulation in this patient cohort. In the present study the investigators evaluate whether PES is safe, feasible and effective in orotracheal intubated stroke patients at high risk of extubation failure.

Conditions

  • Stroke
  • Dysphagia
  • Extubation Failure

Interventions

  • Pharyngeal Electrical Stimulation (PES)Device

    PES will be delivered by a commercial device (Phagenyx, Phagenesis Ltd, Manchester, UK), which comprises a nasogastric feeding catheter that houses stimulation ring-electrodes and a computerised base station that delivers stimulation in the range 1-50 mA at 5 Hz.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful extubationTime frame: 72 hours after extubation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Hospital Münster, Deparment of Neurology

    Münster, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.